GB0328023D0 - Novel compositions - Google Patents

Novel compositions

Info

Publication number
GB0328023D0
GB0328023D0 GBGB0328023.7A GB0328023A GB0328023D0 GB 0328023 D0 GB0328023 D0 GB 0328023D0 GB 0328023 A GB0328023 A GB 0328023A GB 0328023 D0 GB0328023 D0 GB 0328023D0
Authority
GB
United Kingdom
Prior art keywords
novel compositions
compositions
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0328023.7A
Other versions
GB2399286A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SIRUS PHARMACEUTICALS Ltd
Original Assignee
SIRUS PHARMACEUTICALS Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SIRUS PHARMACEUTICALS Ltd filed Critical SIRUS PHARMACEUTICALS Ltd
Publication of GB0328023D0 publication Critical patent/GB0328023D0/en
Priority to NZ541781A priority Critical patent/NZ541781A/en
Priority to EP04719527A priority patent/EP1608372A2/en
Priority to PCT/GB2004/001037 priority patent/WO2004080382A2/en
Priority to CN2004800051154A priority patent/CN1784228B/en
Priority to JP2006500257A priority patent/JP2006519770A/en
Priority to KR1020057016853A priority patent/KR20050115276A/en
Priority to BRPI0408209-5A priority patent/BRPI0408209A/en
Priority to CA002516338A priority patent/CA2516338A1/en
Priority to AU2004218876A priority patent/AU2004218876B2/en
Priority to MXPA05009602A priority patent/MXPA05009602A/en
Publication of GB2399286A publication Critical patent/GB2399286A/en
Priority to NO20054172A priority patent/NO20054172L/en
Priority to US11/224,383 priority patent/US20060062812A1/en
Priority to HK05112165.9A priority patent/HK1084012A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
GB0328023A 2003-03-11 2003-12-03 Sub-lingual fentanyl formulation Withdrawn GB2399286A (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
MXPA05009602A MXPA05009602A (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl.
BRPI0408209-5A BRPI0408209A (en) 2003-03-11 2004-03-11 new compositions
CA002516338A CA2516338A1 (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl
PCT/GB2004/001037 WO2004080382A2 (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl
CN2004800051154A CN1784228B (en) 2003-03-11 2004-03-11 Novel compositions
JP2006500257A JP2006519770A (en) 2003-03-11 2004-03-11 New composition
KR1020057016853A KR20050115276A (en) 2003-03-11 2004-03-11 Novel compositions
NZ541781A NZ541781A (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl
EP04719527A EP1608372A2 (en) 2003-03-11 2004-03-11 Compositions containing fentanyl
AU2004218876A AU2004218876B2 (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl
NO20054172A NO20054172L (en) 2003-03-11 2005-09-07 New mixtures
US11/224,383 US20060062812A1 (en) 2003-03-11 2005-09-12 Novel compositions
HK05112165.9A HK1084012A1 (en) 2003-03-11 2005-12-30 Compositions containing fentanyl

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0305579.5A GB0305579D0 (en) 2003-03-11 2003-03-11 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
GB0328023D0 true GB0328023D0 (en) 2004-01-07
GB2399286A GB2399286A (en) 2004-09-15

Family

ID=9954572

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0305579.5A Ceased GB0305579D0 (en) 2003-03-11 2003-03-11 Pharmaceutical compositions
GB0328023A Withdrawn GB2399286A (en) 2003-03-11 2003-12-03 Sub-lingual fentanyl formulation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0305579.5A Ceased GB0305579D0 (en) 2003-03-11 2003-03-11 Pharmaceutical compositions

Country Status (4)

Country Link
CN (1) CN1784228B (en)
GB (2) GB0305579D0 (en)
HK (1) HK1084012A1 (en)
ZA (1) ZA200506248B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101378735B (en) 2006-01-25 2013-04-03 英西斯治疗学股份有限公司 Sublingual fentanyl spray
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
ES2668366T3 (en) 2007-08-02 2018-05-17 Insys Development Company, Inc. Sublingual fentanyl spraying

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7547891A (en) * 1990-03-30 1991-10-30 Yasunori Morimoto Percutaneously absorbable composition of narcotic and nonnarcotic analgesics
DK1642578T3 (en) * 2000-07-31 2013-08-12 Takeda Pharma As Fentanyl salt composition for nasal administration
CN2474155Y (en) * 2000-12-12 2002-01-30 王玉文 Pen shaped atomizer with rotary jet tube

Also Published As

Publication number Publication date
HK1084012A1 (en) 2006-07-21
CN1784228A (en) 2006-06-07
ZA200506248B (en) 2006-10-25
GB2399286A (en) 2004-09-15
GB0305579D0 (en) 2003-04-16
CN1784228B (en) 2012-06-06

Similar Documents

Publication Publication Date Title
GB0305941D0 (en) Composition
IL171942A0 (en) Compositions containing ecteinascidin-743
GB0302738D0 (en) Composition
GB0329907D0 (en) Compositions
EP1613352A4 (en) Micro-cluster compositions
GB0329597D0 (en) Compositions
GB0318824D0 (en) Novel composition
GB0305790D0 (en) Novel Composition
GB0322033D0 (en) Composition
GB0229808D0 (en) Novel compositions
GB0300602D0 (en) Compositions
GB0324574D0 (en) Novel compositions
GB0328023D0 (en) Novel compositions
GB0309317D0 (en) Composition
GB0228540D0 (en) Novel compositions
GB0316857D0 (en) Compositions
GB0306312D0 (en) Composition
GB0314836D0 (en) Novel compositions
GB0301869D0 (en) Composition
GB0326075D0 (en) Compositions
GB0310479D0 (en) Compositions
GB0322118D0 (en) Arthropodicdal compositions
GB0322117D0 (en) Arthropodicdal compositions
GB0321725D0 (en) Anti-vaginitis compositions
GB0319649D0 (en) Compositions

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)